Results 171 to 180 of about 31,394 (214)

Rosuvastatin

Reactions Weekly, 2016
  +8 more sources

Rosuvastatin

Reactions Weekly, 2023
  +5 more sources

Rosuvastatin suppresses cytokine production and lung inflammation in asthmatic, hyperlipidemic and asthmatic-hyperlipidemic rat models.

Cytokine, 2020
BACKGROUND Given the role that T lymphocytes play on the pathogenesis of allergic asthma, drugs targeting Th2 and Th17 cells may be a hopeful therapeutic strategy.
S. Saadat, N. Mohamadian Roshan, M. Aslani, M. Boskabady   +3 more
semanticscholar   +1 more source

An overview of rosuvastatin/ezetimibe association for the treatment of hypercholesterolemia and mixed dyslipidemia

Expert Opinion on Pharmacotherapy, 2020
Introduction Although statin therapy is a powerful lipid-lowering strategy, only one-fifth of statin users currently reach their lipid goals. In addition, statin treatment alone has relatively low efficacy in reducing other lipid fractions than low ...
L. Strilchuk, G. Tocci, F. Fogacci, A. Cicero   +3 more
semanticscholar   +1 more source

Effect of Rosuvastatin in Preventing Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer: A Randomized, Single-Blind, Placebo-Controlled Trial

Journal of Cardiovascular Pharmacology and Therapeutics, 2019
Objective: Chemotherapy-induced cardiotoxicity is a major and leading cause of death in breast cancer survivors. It can present decades after chemotherapy and can manifest in different ways; some chemotherapeutic agents have a powerful dose-dependent ...
M. Nabati, G. Janbabai, Jamil Esmailian, J. Yazdani   +3 more
semanticscholar   +1 more source

High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion.

International Journal of Cardiology, 2020
BACKGROUND ATP-binding cassette A1 (ABCA1) and G1 (ABCG1) mediate cholesterol efflux from lipid-laden macrophages, thus promoting anti-atherosclerotic outcomes.
D. Santovito, P. Marcantonio, D. Mastroiacovo, L. Natarelli, C. Mandolini, Velia de Nardis, Camilla Paganelli, D. de Cesare, Giannapia Affaitati, M. Giamberardino, L. Stellin, M. Pinelli, C. Weber, G. De Blasis, U. Occhiuzzi, M. Bucci, G. Desideri, F. Cipollone   +17 more
semanticscholar   +1 more source

Mesenchymal stem cells associated with chitosan scaffolds loaded with rosuvastatin to improve wound healing

European Journal of Pharmaceutical Sciences, 2019
In this study we explored the role of rosuvastatin calcium in skin regeneration as statins play important role in the field of tissue engineering. Chitosan hydrochloride was crosslinked with different weight ratios of collagen, &bgr;‐glycerolphosphate ...
A. Maged, A. A. Abdelkhalek, Azza A K Mahmoud, Salwa Salah, Mohamed M. Ammar, M. Ghorab   +5 more
semanticscholar   +1 more source

Rosuvastatin

Reactions Weekly, 2020
  +4 more sources

Pharmacokinetics of Rosuvastatin: A Systematic Review of Randomised Controlled Trials in Healthy Adults

Clinical Pharmacokinetics, 2021
R. Kanukula, A. Salam, A. Rodgers, Bishoy Kamel   +3 more
semanticscholar   +1 more source

Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case–control study

European Journal of Clinical Pharmacology, 2021
I. Merćep, I. Radman, V. Trkulja, T. Božina, L. Šimičević, Ema Budimir, L. Ganoci, N. Božina   +7 more
semanticscholar   +1 more source